Revenue: The sum of all revenue fields included for a company's operating activities.
Iterum Therapeutics PLC (ITRM) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-24.77M |
|
$0.25M |
|
$-0.25M |
|
$18.70M |
|
$-18.70M |
|
$-5.84M |
|
$-24.53M |
|
$-24.53M |
|
$-24.77M |
|
$-24.77M |
|
$-24.77M |
|
$-24.77M |
|
$-18.70M |
|
$-16.12M |
|
19.70M |
|
19.70M |
|
$-1.26 |
|
$-1.26 |
|
| Balance Sheet Financials | |
$24.79M |
|
$0.02M |
|
$19.81M |
|
$44.59M |
|
$17.61M |
|
$20.30M |
|
$31.07M |
|
$48.68M |
|
$-4.08M |
|
$-23.83M |
|
$-4.08M |
|
31.53M |
|
| Cash Flow Statement Financials | |
$-26.77M |
|
$18.21M |
|
$26.69M |
|
$6.11M |
|
$24.16M |
|
$18.05M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.41 |
|
-- |
|
-- |
|
1.25 |
|
-4.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
607.06% |
|
103.97% |
|
-55.55% |
|
-152.75% |
|
$-0.13 |
|
$-1.36 |
|
$-1.36 |
|